, Hôpital Tenon, Service Maladies infectieuses et tropicales
Assistance Publique des Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Service des maladies infectieuses et tropicales, Unité d'Hépatologie, AP-HP Hôpital Cochin, USM20, Institut Pasteur, Université Paris-Descartes, p.94800, 92296. ,
Zucman: Hôpital Foch, unité VIH, Service Médecine interne et immunologie, Clamart 92140, France. P. Miailhes: Service des Maladies Infectieuses et Tropicales ,
Clinical Centres (ward / participating physicians): APHP, Hôpitaux Universitaires Paris Centre, Paris (Médecine Interne et Maladies Infectieuses: D. Salmon, R. Usubillaga; Hépatogastro-entérologie: P. Sogni, p.75013 ,
, Maladies Infectieuses et Tropicales: C. Katlama, M.A. Valantin, H. Stitou
, Virologie: S. Fourati
,
, Virologie: C. Tamalet)
,
, Toulouse (Maladies Infectieuses et Tropicales: B. Marchou; Médeicne interne: L. Alric; Hépato-gastro-entérologie: K. Barange, S. Metivier
, Virologie: F. Larroquette)
, Infectiologie: A. Naqvi, V. Rio; Anatomo-pathologie
,
,
, Virologie: F. Nicot
,
, Pharmacologie: G. Peytavin)
, Anatomopathologie: P. Bertheau; Virologie: M.L. Chaix
, Maladies Infectieuses et Tropicales
, Maladies Infectieurses et Tropicales: D. Vittecocq; Médecine Interne
, Virologie: V. Avettand-Fenoel, E. Gardiennet, A. Mélard
, Maladies Infectieuses et Tropicales: D. Neau
, Médecine Interne et Maladies Infectieuses
, Virologie: P. Trimoulet, S. Reigadas
,
, Virologie: C. Deback)
, Nantes (Maladies Infectieuses et Tropicales: E. Billaud
, C. Hemon)
, Lyon (Maladies Infectieuses et Tropicales: P
,
, Virologie: C. Scholtes, T.T. Le-Thi
, Maladies infectieuses et tropicales: H. Aumaître, Virologie: S. Galim)
, Médecine interne, maladies infectieuses et immunologie clinique
, Management
,
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. The Lancet Infectious diseases, vol.16, pp.485-490, 2016. ,
Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival, PloS one, vol.11, issue.3, 2016. ,
High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between, Epub 2015/05/06, vol.63, pp.573-80, 2001. ,
Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus, Hepatology, vol.50, issue.4, pp.1056-63, 2009. ,
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults, Aids, vol.21, issue.16, pp.2209-2225, 2007. ,
Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population, 2003. ,
, Aids, vol.28, issue.13, pp.1957-65, 2014.
Causes of death among HIVinfected patients in France in 2010 (national survey): trends since, Aids, vol.28, issue.8, pp.1181-91, 2000. ,
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals, Aids, vol.29, issue.10, pp.1205-1220, 2015. ,
Trends in underlying causes of death in people with HIV from, Lancet, vol.384, issue.9939, pp.241-249, 1999. ,
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study, Lancet, vol.356, issue.9244, pp.1800-1805, 2000. ,
Effect of early versus deferred antiretroviral therapy for HIV on survival. The New England journal of medicine, vol.360, pp.1815-1841, 2009. ,
Decline in the AIDS and death rates in the EuroSIDA study: an observational study, Lancet, vol.362, issue.9377, pp.22-31, 2003. ,
Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study, 2016. ,
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, vol.33, pp.562-571, 2001. ,
Progression of liver fibrosis in HIV/ hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. HIV medicine, vol.15, pp.203-215, 2013. ,
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, nonrandomised, phase 3 study, Lancet, vol.385, issue.9973, pp.62483-62484, 2015. ,
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection, Jama, vol.313, issue.12, pp.1232-1241, 2015. ,
Efficacy and safety of directacting antiviral regimens in HIV/HCV-coinfected patients-French ANRS CO13 HEPAVIH cohort ,
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, vol.63, pp.763-70, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01993207
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV, Jama, vol.308, issue.4, pp.370-378, 2012. ,
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients. Open forum infectious diseases, vol.2, 2015. ,
Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV, Aids, vol.30, issue.5, pp.723-732, 2015. ,
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus, Hepatology, vol.50, issue.2, pp.407-420, 2009. ,
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus, vol.55, pp.728-764, 2012. ,
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis, Journal of acquired immune deficiency syndromes, vol.66, issue.3, pp.280-287, 2014. ,
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C viruscoinfected patients with compensated cirrhosis, vol.56, pp.1646-53, 2013. ,
Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response. Digestive diseases and sciences, Epub 2015/06/27, vol.60, p.26112991, 2015. ,
Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients, Aids, vol.29, issue.14, pp.1821-1851, 2015. ,
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients, Journal of acquired immune deficiency syndromes, vol.41, issue.2, pp.175-184, 2006. ,
The French national prospective cohort of patients co-infected with HIV and HCV, ANRS CO13 HEPAVIH): early findings, vol.10, p.303, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01070193
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy, PloS one, vol.10, issue.9, 2015. ,
The metabolic syndrome-a new worldwide definition, Lancet, vol.366, issue.9491, pp.1059-62, 2005. ,
Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach, Biostatistics, vol.10, issue.3, pp.535-584, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00367752
JM: An R Package for the Joint Modelling of Longitudinal and Time-to-Event Data, Journal of Statistical Software, vol.35, issue.9, 2010. ,
Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era. AIDS research and human retroviruses, vol.28, pp.1235-1278, 2012. ,
Effect of hepatitis C virus and its treatment on survival, Hepatology, vol.50, issue.2, pp.387-92, 2009. ,
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection, Lancet, vol.362, issue.9397, pp.1708-1721, 2003. ,